- Home
- Publications
- Publication Search
- Publication Details
Title
Role of toll-like receptor 4 in diabetic retinopathy
Authors
Keywords
Diabetic retinopathy, Toll-like receptor 4, Inflammation, Neovascularization, Oxidative stress, Neurodegeneration, Single nucleotide polymorphism, MicroRNA, Novel therapies
Journal
PHARMACOLOGICAL RESEARCH
Volume 175, Issue -, Pages 105960
Publisher
Elsevier BV
Online
2021-10-29
DOI
10.1016/j.phrs.2021.105960
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Does Hyperglycemia Cause Oxidative Stress in the Diabetic Rat Retina?
- (2021) Mohammad Shamsul Ola Cells
- A Computational Approach for Mapping Heme Biology in the Context of Hemolytic Disorders
- (2020) Farah Humayun et al. Frontiers in Bioengineering and Biotechnology
- Toll-like Receptors and the Control of Immunity
- (2020) Katherine A. Fitzgerald et al. CELL
- microRNA-499-3p inhibits proliferation and promotes apoptosis of retinal cells in diabetic retinopathy through activation of the TLR4 signaling pathway by targeting IFNA2
- (2020) Xiaomeng Liu et al. GENE
- Serum Iron and Risk of Diabetic Retinopathy
- (2020) Ying-Jen Chen et al. Nutrients
- The Complex Relationship between Diabetic Retinopathy and High-Mobility Group Box: A Review of Molecular Pathways and Therapeutic Strategies
- (2020) Marcella Nebbioso et al. Antioxidants
- Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression
- (2020) W. Li et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Protective effect of metformin on rat diabetic retinopathy involves suppression of toll-like receptor 4/nuclear factor-k B expression and glutamate excitotoxicity
- (2020) Suliman Y. Alomar et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Nicotine Modulates MyD88-Dependent Signaling Pathway in Macrophages during Mycobacterial Infection
- (2020) Dania AlQasrawi et al. Microorganisms
- Ceramides and diabetes mellitus: an update on the potential molecular relationships
- (2019) H. Yaribeygi et al. DIABETIC MEDICINE
- Unveiling the Interplay between the TLR4/MD2 Complex and HSP70 in the Human Cardiovascular System: A Computational Approach
- (2019) Amanda Almeida de Oliveira et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Apocynin ameliorates diabetic retinopathy in rats: Involvement of TLR4/NF-κB signaling pathway
- (2019) Yixin Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- B cell receptor and Toll-like receptor signaling coordinate to control distinct B-1 responses to both self and the microbiota
- (2019) Lieselotte SM Kreuk et al. eLife
- Exosomes derived from platelet-rich plasma mediate hyperglycemia-induced retinal endothelial injury via targeting the TLR4 signaling pathway
- (2019) Wei Zhang et al. EXPERIMENTAL EYE RESEARCH
- Role of Inflammation in Diabetic Retinopathy
- (2018) Anne Rübsam et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-145 attenuates high glucose-induced oxidative stress and inflammation in retinal endothelial cells through regulating TLR4/NF-κB signaling
- (2018) Ying Hui et al. LIFE SCIENCES
- Inhibition of TLR4 alleviates the inflammation and apoptosis of retinal ganglion cells in high glucose
- (2017) Lili Hu et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Paeoniflorin Suppressed High Glucose-Induced Retinal Microglia MMP-9 Expression and Inflammatory Response via Inhibition of TLR4/NF-κB Pathway Through Upregulation of SOCS3 in Diabetic Retinopathy
- (2017) Su-Hua Zhu et al. INFLAMMATION
- Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells
- (2017) Sarang Tartey et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK
- (2017) Edina Schweighoffer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Loss of TLR4 in mouse Müller cells inhibits both MyD88-dependent and –independent signaling
- (2017) Li Liu et al. PLoS One
- Inhibition of HMGB1 protects the retina from ischemia-reperfusion, as well as reduces insulin resistance proteins
- (2017) Li Liu et al. PLoS One
- HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo
- (2017) shuang jiang et al. Drug Design Development and Therapy
- The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients
- (2016) Monika Buraczynska et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Toll-like receptor (TLR)-2/4 expression in retinal ganglion cells in a high-glucose environment and its implications
- (2016) M. Zhao et al. GENETICS AND MOLECULAR RESEARCH
- β-Adrenergic receptor agonist, compound 49b, inhibits TLR4 signaling pathway in diabetic retina
- (2016) Elizabeth A Berger et al. IMMUNOLOGY AND CELL BIOLOGY
- Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus
- (2016) Elliott H. Sohn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways
- (2015) Kannan Badri Narayanan et al. APOPTOSIS
- The association between toll-like receptor 4 polymorphisms and diabetic retinopathy in Chinese patients with type 2 diabetes
- (2015) Yuxin Xu et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- High glucose induces and activates Toll-like receptor 4 in endothelial cells of diabetic retinopathy
- (2015) Lu Wang et al. Diabetology & Metabolic Syndrome
- HMGB-1 as a Potential Target for the Treatment of Diabetic Retinopathy
- (2015) Hailan Zhao et al. MEDICAL SCIENCE MONITOR
- Discovery of substituted 4-aminoquinazolines as selective Toll-like receptor 4 ligands
- (2014) Afshin Nour et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer
- (2014) A Trejo-de la O et al. GENES AND IMMUNITY
- Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats
- (2014) Yan-Ling Wang et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- High-mobility group box-1 and its role in angiogenesis
- (2014) S. Yang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Toll-Like Receptor 4 in Bone Marrow-Derived Cells Contributes to the Progression of Diabetic Retinopathy
- (2014) Hui Wang et al. MEDIATORS OF INFLAMMATION
- Beneficial effects of the nutritional supplements on the development of diabetic retinopathy
- (2014) Renu A Kowluru et al. Nutrition & Metabolism
- Heme on innate immunity and inflammation
- (2014) Fabianno F. Dutra et al. Frontiers in Pharmacology
- Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy inIns2Akitamice
- (2013) Nermina N Vagaja et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition
- (2013) Xiao-Li Chen et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- MyD88-Dependent Pathways in Leukocytes Affect the Retina in Diabetes
- (2013) Jie Tang et al. PLoS One
- Pathophysiology and treatment of diabetic retinopathy
- (2012) Francesco Bandello et al. ACTA DIABETOLOGICA
- Angiogenesis Mediated by Toll-Like Receptor 4 in Ischemic Neural Tissue
- (2012) Chang He et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications
- (2012) Ishwarlal Jialal et al. Current Diabetes Reports
- The Mycobacterium aviumsubsp.paratuberculosisfibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency
- (2012) Kyung Tae Noh et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina
- (2012) Ghulam Mohammad et al. EXPERIMENTAL EYE RESEARCH
- Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation
- (2012) J. M. Reynolds et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology
- (2011) Min K Song et al. BRITISH JOURNAL OF PHARMACOLOGY
- Epigenetic mechanisms in diabetic vascular complications
- (2011) M. A. Reddy et al. CARDIOVASCULAR RESEARCH
- Toll-like receptors
- (2011) Eva Marie Y. Moresco et al. CURRENT BIOLOGY
- Anti-inflammatory therapy for diabetic retinopathy
- (2011) Wenbo Zhang et al. Immunotherapy
- Altered MicroRNA Expression Profiles in Retinas with Diabetic Retinopathy
- (2011) Jin-hui Wu et al. OPHTHALMIC RESEARCH
- Inflammation in diabetic retinopathy
- (2011) Johnny Tang et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Muller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage
- (2010) J. Wang et al. DIABETES
- TLR-signaling Networks
- (2010) J. Brown et al. JOURNAL OF DENTAL RESEARCH
- Endogenous Inflammatory Molecules Engage Toll-Like Receptors in Cardiovascular Disease
- (2010) Mihaela G. Ionita et al. Journal of Innate Immunity
- TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
- (2010) N. Matsunaga et al. MOLECULAR PHARMACOLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes
- (2009) Monika Buraczynska et al. HUMAN IMMUNOLOGY
- Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)
- (2008) Judy R. van Beijnum et al. ANGIOGENESIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started